Biora Therapeutics, Inc.
Biora Therapeutics, Inc. (BIOR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bior · stock forecast · 1 analysts (3M) · FMP · updated Feb 12, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.22
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BIOR · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-01-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-07-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Biora Therapeutics, Inc. (BIOR) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover BIOR.
Analyst Recommendation Trends
BIOR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 80.0% YoY
Revenue Next Year
$5M
↑ 354.5% YoY
EPS This Year
$-8.83
EPS Next Year
$-5.13
↓ 41.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast BIOR EPS of $-8.83 for the current fiscal year, based on estimates from 1 analysts. The BIOR revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BIOR stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BIOR price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
Biora Therapeutics, Inc. trades on OTC under the ticker BIOR. The BIOR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BIOR forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month BIOR price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.22.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.